Cheng-Yuan Peng

50PUBLICATIONS
99CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineMajor global burdens of diseaseCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Sep 07, 2026
Machine Learning Model for Predicting Hepatocellular Carcinoma Development in Patients With Hepatitis B Virus-Related Cirrhosis Receiving Antiviral Therapy.

|Apr 20, 2026
Absence of steatosis combined with cardiometabolic risk factors confers the highest hepatocellular carcinoma risk in treated chronic hepatitis B.

|Nov 14, 2025
Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Yun-Chu Chen, Yu-Ping Chang, Ji-Yuh Lee

|Oct 20, 2025
Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral Eradication.

Wei-Fan Hsu, Ching-Chu Lo, Kuo-Chih Tseng

|Jun 20, 2025
Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan.

Szu-Jen Wang, Te-Sheng Chang, Ching-Chu Lo

|May 24, 2025
Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.

Ping-Jen Hu, Pei-Chien Tsai, Chi-Yi Chen

Pageof 9

Frequent Collaborators

16 joint publications

Jia-Horng Kao

11 joint publications

Chen-Hua Liu

11 joint publications

Ming-Lung Yu

9 joint publications

Wei-Fan Hsu